FERTYBIOTIC
FERTYBIOTIC WOMEN 30 SACHETS
FERTYBIOTIC WOMEN 30 SACHETS
Secure payment
Discreet and sanitized package
Fast and safe shipping
Description
Description
FertyBiotic
Woman
food supplement specifically formulated for the female body of childbearing age, containing myo-inositol, D-chiro-inositol, folic acid, melatonin, selenium, vitamin D and probiotic ferments.
Folic acid: Folic acid supplementation increases maternal folate status. Low maternal folate status is a risk factor for the development of neural tube defects in the fetus. The product is intended for women of childbearing age; the beneficial effect is obtained with a daily folic acid supplementation of 400 g for at least one month before and up to three months after conception. Folate contributes to maternal tissue growth during pregnancy. The product contains Quatrefolic folate (registered trademark of Gnosis SpA), an active form of folic acid with increased bioavailability.
Selenium: contributes to the protection of cells from oxidative stress.
Vitamin D: intervenes in the process of cell division.
Probiotics (Lacticaseibacillus rhamnosus BPL205, Lactobacillus crispatus BIO6272, Lactiplantibacillus plantarum BPL207): promote the balance of intestinal flora.
The formula also provides myo-inositol and D-chiro-inositol, two isomers of inositol classified as B-group pseudovitamins because they are also synthesized by the body, and melatonin, a hormone produced by the pineal gland.
Ingredients
Bulking agent: lactitol; myo-inositol, D-chiro-inositol, natural flavouring; anti-caking agent: tricalcium phosphate; Lacticaseibacillus rhamnosus BPL205, Lactobacillus crispatus BIO6272, Lactiplantibacillus plantarum BPL207, vitamin D (cholecalciferol); sweetener: sucralose; melatonin; folic acid [(6S)-5-methyltetrahydrofolic acid, glucosamine salt] (Quatrefolic), sodium selenite.
Gluten and lactose free.
Nutritional characteristics
| Average values | for 1 sachet | %VNR* |
| Myo-inositol | 2 g | |
| D-chiro-inositol | 210.5 mg | |
| Folic Acid (Quatrefolic) | 400 mcg | 200% |
| Selenium | 55 mcg | 100% |
| Vitamin D3 | 15 mcg | 300% |
| Melatonin | 1 mg | |
| Lacticaseibacillus rhamnosus BPL205 | 1 x 10 9 UFC** | |
| Lactobacillus crispatus BIO6272 | 1 x 10 9 UFC** | |
| Lactiplantibacillus plantarum BPL207 | 1 x 10 9 UFC** |
**UFC: Colony Forming Units
How to use
Take the contents of one sachet per day, diluted in 200 ml of water, preferably in the evening.
Warnings
Food supplements should not be used as a substitute for a varied, balanced diet and a healthy lifestyle. Do not exceed the recommended daily dose. Keep out of reach of children under 3 years of age. Excessive consumption may produce laxative effects.
Conservation
FertyBiotic Donna contains heat-sensitive live probiotics. It is recommended to avoid exposing the product to heat sources or sudden changes in temperature, storing it in a cool, dry place, below 25°C.
Format
30 sachets.
Cod. 100951
FERTYBIOTIC
FERTYBIOTIC WOMEN 30 SACHETS
FERTYBIOTIC WOMEN 30 SACHETS
Couldn't load pickup availability
Product images are purely indicative and may not be fully representative of the packaging and product features, as they may vary in color, size, or content. Any decorations, gift wrapping, and items included in the images for product presentation purposes will not be shipped with orders. Product names, ingredients, and percentages indicated in the descriptions are purely indicative and may be subject to change or updates by the manufacturers. Due to the impossibility of updating these updates in real time, the photos and technical information of the products listed on farmaInnovation.it may differ from those shown on the label or otherwise disclosed by the manufacturers. The only identifying element is the MINSAN (Ministry of Health) code. Farmacia Barni, farmainnovation.it , does not guarantee the accuracy and timeliness of the information published and declines all responsibility for any errors, omissions, or failure to update it. farmainnovation.it assumes no responsibility for damages of any kind that may arise from accessing the published information.
